First Time Loading...

Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 5.7615 USD -7.37% Market Closed
Updated: May 27, 2024

Collplant Biotechnologies Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Collplant Biotechnologies Ltd
Research & Development Peer Comparison

Comparables:
KMDA
B
BLRX
URGN
ENTX
B
BONS

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Research & Development
-$10.5m
CAGR 3-Years
-42%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Research & Development
-$15m
CAGR 3-Years
-5%
CAGR 5-Years
-9%
CAGR 10-Years
-2%
B
BioLine RX Ltd
TASE:BLRX
Research & Development
-$11.9m
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
0%
Urogen Pharma Ltd
NASDAQ:URGN
Research & Development
-$48.6m
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Research & Development
-$4.5m
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Research & Development
-₪18.6m
CAGR 3-Years
-22%
CAGR 5-Years
-12%
CAGR 10-Years
-13%

See Also

What is Collplant Biotechnologies Ltd's Research & Development?
Research & Development
-10.5m USD

Based on the financial report for Dec 31, 2023, Collplant Biotechnologies Ltd's Research & Development amounts to -10.5m USD.

What is Collplant Biotechnologies Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-21%

Over the last year, the Research & Development growth was -2%. The average annual Research & Development growth rates for Collplant Biotechnologies Ltd have been -42% over the past three years , -21% over the past five years .